Immunostimulatory agent

Details Immunostimulatory agent Immunostimulatory agent

1993-02-19

1995-11-14

Warden, Jill

Drug, bio-affecting and body treating compositions

Designated organic active ingredient containing

Peptide containing doai

530324, A61K 3800, C07K 500, C07K 700, C07K 1700

Patent

active

054666694

DESCRIPTION:

BRIEF SUMMARY
TECHNICAL FIELD

This invention relates to an immunostimulatory agent comprising a peptide derived from lactoferrin having activity to modulate the release of inflammatory mediators from cells of the immune system and thereby potentiate the cellular immune response. In particular, the present invention relates to a peptide derived from lactoferrin having at least the following activities: (1) promotes the release of leukotriene B4 from polymorphonuclear neutrophils; (2) promotes the release of histamine from mast cells.


BACKGROUND ART

Polymorphonuclear neutrophils and mast cells play major role in the host defense against bacterial, fungal and viral infections. Microorganisms or their products, can interact directly with these cells and induce the release of inflammatory mediators such as leukotrienes and histamine which have multiple effects essential to amplification and control of the inflammatory response. Leukotriene B4 is a potent chemotactic and chemokinetic factor which attracts neutrophils, eosinophils, monocytes and macrophages to sites of infection and tissue trauma. It promotes the aggregation of neutrophils, augments their adherence to endothelial cells, stimulates the release of lysozomal enzymes and the production of superoxide. It also inhibits the proliferation of lymphocytes via the induction of suppressor T cells and augments cytotoxic and natural killer cell activities. On the other hand, leukotrienes C4, D4, and E4 are the slow-reacting substances of anaphylaxis which cause long-lasting contraction of smooth muscle, bronchoconstriction, vasoconstriction, secretion of mucous, and an increase in vascular permeability. Histamine induces vasodilation, increase in vascular permeability, stimulation of secretory glands and contraction of smooth muscle. Furthermore, histamine modulates certain immune effector functions such as cell-mediated cytotoxicity, lymphocyte proliferation, lymphokine production, and immunoglobulin synthesis. In general, the biological actions of leukotriene B4 and histamine tend to potentiate the cellular immune response and stimulate the host defense against microbial infections.
It is widely recognized that the biological actions of leukotriene B4 relating to recruitment and stimulation of neutrophils are essential for the host defense against microbial infections. The migration of polymorphonuclear neutrophils from circulating blood to the focus of infection is one of the earliest events of the inflammatory process. The cells leave the circulation and are guided towards sites of infection and tissue trauma by chemotaxis, in response to chemotatic factors released in the vicinity of invading microorganisms. Leukotriene B4 is the most potent chemotactic stimulus for neutrophils. The chemotactic stimulus promotes cellular movement and enables a variety of subsequent steps essential to the host defense including attachment, engulfment, ingestion, degranulation, secretion of lysozomal enzymes into phagolysozomes, and generation of toxic oxygen radicals, which ultimately lead to killing of invading microorganisms. Neutrophils control the concentration of leukotriene B4 in their environment by generating and metabolizing this inflammatory mediator. Leukotriene B4 is bound by specific receptors on the cell surface, internalized, and enzymatically oxidized producing biologically inactive products, 20-OH-leukotriene B4 and 20-COOH-leukotriene B4. In the case of major injuries, such as severely burned patients, the chemotactic responsiveness of neutrophils is impaired. Their production and release of leukotriene B4 is diminished, the metabolism of leukotriene B4 to inactive 20-OH-leukotriene B4 and 20-COOH-leukotriene B4 is enhanced, and the expression of leukotriene B4 receptors on the cell surface is reduced. Decreased production of leukotriene B4 and reduced responsiveness to leukotriene B4 leads to inadequate recruitment of phagocytes at sites of tissue injury and precedes the onset of microbial invasion.
Lactoferrin is an iron-binding glycoprotein present in various bi

REFERENCES:
Zimecki et al., Chem. Abstrs, vol. 116, No. 5, 1992, Abst No: 39616u.
Zimecki et al, Chem Abstrs, vol. 108, No. 13, 1988, Abst. No. 110658b.

Affiliated with

Also associated with

Rating

Immunostimulatory agent does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Immunostimulatory agent, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Immunostimulatory agent will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-1220961